Samrat Pharmachem Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 20 shareholders own 62.73% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14%	Lalit Mehta	431,498	₹165.4m	0%	no data
12.4%	Rajesh Mehta	383,542	₹147.1m	0%	no data
5.67%	Premal Mehta	175,281	₹67.2m	0%	no data
4.5%	Kaushal Mehta	139,065	₹53.3m	0%	no data
3.86%	Jaya Mehta	119,300	₹45.7m	0%	no data
3.27%	S. Sangeetha	101,000	₹38.7m	0%	no data
3.24%	Lloyds Securities Overseas Ltd	100,000	₹38.3m	0%	no data
2.66%	Rupal Mehta	82,182	₹31.5m	0%	no data
2.15%	Falguni Mehta	66,400	₹25.5m	0%	no data
2.11%	Golechha Global Finance Limited, Asset Management Arm	65,240	₹25.0m	0%	no data
1.64%	Kalpana Mehta	50,600	₹19.4m	0%	no data
1.53%	Alert Consultants & Credit Private Limited, Asset Management Arm	47,169	₹18.1m	0%	no data
1.51%	Megh Mehta	46,650	₹17.9m	0%	no data
1.31%	Anshul Specialty Molecules Private Limited	40,444	₹15.5m	0%	no data
1.13%	Sharad Shah	35,000	₹13.4m	0%	no data
0.42%	Rajasthan Global Securities Limited, Asset Management Arm	13,087	₹5.0m	0%	0.06%
0.4%	Divyanshu Kantol	12,500	₹4.8m	0%	no data
0.36%	Ponguleti Reddy	10,971	₹4.2m	0%	no data
0.32%	Rajendra Sanghavi	10,000	₹3.8m	0%	no data
0.27%	Maitri Mehta	8,244	₹3.2m	0%	no data